[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6151 followers
Created: 2025-07-25 10:12:23 UTC

Solara Active Pharma Q1 FY26: Margins Expand, Debt Declines 📊💊 | MCap XXXXXXXX Cr

- Q1 FY26 Revenue: INR XXXXX Mn (↓12% YoY, ↑15% QoQ)
- Gross Margin: XXXX% (↑960 bps YoY) on better product mix & cost control
- EBITDA: INR XXX Mn (↑36% YoY, ↑13% QoQ), margin at XXXX%
- PAT: INR XXX Mn (first profit after losses, best in XX quarters)
- XX% revenue from Regulated Markets (stable QoQ)
- Gross Debt reduced by INR XXXXX Mn to INR XXXXX Mn (further cuts expected)
- Net Debt target: INR XXXXX Mn by May 2026 (Net Debt/EBITDA ~2x)
- CRAMS & Polymers biz carved out into new entity 'Synthix Global Pharma Solutions'
- Legacy API biz to shed INR XXXXX Mn debt via restructuring

Complete Source:

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Preview 👇 (First X out of XX pages)

![](https://pbs.twimg.com/media/GwshC82aYAAYWI9.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948687766600204711/c:line.svg)

**Related Topics**
[losses](/topic/losses)
[indian rupee](/topic/indian-rupee)
[mcap](/topic/mcap)
[debt](/topic/debt)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1948687766600204711)